Disease activity assessment in large vessel vasculitis

被引:6
|
作者
Magnani, L. [1 ]
Versari, A. [2 ]
Salvo, D. [2 ]
Casali, M. [2 ]
Germano, G. [1 ]
Meliconi, R. [3 ,4 ]
Pulsatelli, L. [5 ]
Formisano, D. [6 ]
Bajocchi, G. [1 ]
Pipitone, N. [1 ]
Boiardi, L. [1 ]
Salvarani, C. [1 ]
机构
[1] Arcispedale S Maria Nuova, Struttura Complessa Reumatol, Via Risorgimento 80, I-42100 Reggio Emilia, Italy
[2] ASMN, Med Nucl, Reggio Emilia, Italy
[3] IOR, Modulo Reumatol, Bologna, Italy
[4] Univ Bologna, Bologna, Italy
[5] IOR, Lab Immunoreumatol & Genet, Bologna, Italy
[6] ASMN, Epidemiol & Stat, Reggio Emilia, Italy
关键词
Takayasu arteritis; large vessel vasculitis; GCA; Pet; interleukine; 6; disease assessment;
D O I
10.4081/reumatismo.2011.86
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disease activity assessment in large vessel vasculitis (LVV) is often challenging for physicians. In this study, we compared the assessment of disease activity based on inflammatory markers, clinical indices (Indian Takayasu Activity Score [ITAS] and the Kerr/National Institute of Health indices [Kerr/NIH]), and 18F-Fluorodesossi-glucose (FGD) vascular uptake at positron emission tomography (Pet). We found that Pet results did not statistically correlate with the clinical indices ITAS and Kerr/NIH, because FDG uptake was increased (grade> 2 on a 0-3 scale in at least one evaluated vascular segment) in many patients with inactive disease according to clinical and laboratory parameters (i.e., negative ITAS and Kerr/NIH indices as well as normal erythrocyte sedimentation rate (ESR) and C-reactive protein (PCR)). Similarly, interleukin-6 and its soluble receptor did not statistically correlate with disease activity. In contrast, clinical indices showed a significant correlation between each other and with inflammatory markers (VES and PCR). These data suggest that while clinical indices and inflammatory markers may be useful to assess disease activity, Pet may be more sensitive.
引用
收藏
页码:86 / 90
页数:5
相关论文
共 50 条
  • [31] Large vessel vasculitis
    Caspary, L.
    Schellong, S.
    INTERNIST, 2009, 50 (08): : 958 - 963
  • [32] Large vessel vasculitis
    Gulati, Ashima
    Bagga, Arvind
    PEDIATRIC NEPHROLOGY, 2010, 25 (06) : 1037 - 1048
  • [33] Large vessel vasculitis
    Zavadilova, Lucie
    Gergely, Ladislav
    COR ET VASA, 2018, 60 (03) : E251 - E262
  • [34] Large vessel vasculitis
    Maalouf, G.
    REVUE DE MEDECINE INTERNE, 2022, 43 (10): : 45 - 48
  • [35] Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis
    Springer, Jason Michael
    Monach, Paul
    Cuthbertson, David
    Carette, Simon
    Khalidi, Nader A.
    McAlear, Carol A.
    Pagnoux, Christian
    Seo, Philip
    Warrington, Kenneth J.
    Ytterberg, Steven R.
    Hoffman, Gary
    Langford, Carol
    Hamilton, Thomas
    Foell, Dirk
    Vogl, Thomas
    Holzinger, Dirk
    Merkel, Peter A.
    Roth, Johannes
    Hajj-Ali, Rula A.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 (07) : 393 - 395
  • [36] Large vessel vasculitis
    Czihal, Michael
    Hoffmann, Ulrich
    NEPHROLOGE, 2021, 16 (06): : 350 - 359
  • [37] Large vessel vasculitis
    Hall, S
    NEPHROLOGY, 1997, 3 (06) : S789 - S789
  • [38] Angiographic Progression of Disease in Large-Vessel Vasculitis
    Quinn, Kaitlin
    Dashora, Himanshu
    Ahlman, Mark
    Novakovich, Elaine
    Grayson, Peter C.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [39] ANGIOGRAPHIC PROGRESSION OF DISEASE IN LARGE-VESSEL VASCULITIS
    Quinn, K. A.
    Dashora, H.
    Ahlman, M.
    Grayson, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1064 - 1065
  • [40] The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease
    Walter, MA
    Melzer, RA
    Schindler, C
    Müller-Brand, J
    Tyndall, A
    Nitzsche, EU
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (06) : 674 - 681